Healthcare provider profile · identity verified

David Britt, MD

Family Practice · LONGMONT, CO · NPI 1427052836

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	341	108
Atorvastatin Calcium	Atorvastatin Calcium	333	106
Levothyroxine Sodium	Levothyroxine Sodium	298	96
Rosuvastatin Calcium	Rosuvastatin Calcium	270	85
Losartan Potassium	Losartan Potassium	248	78
Omeprazole	Omeprazole	197	57
Simvastatin	Simvastatin	189	56
Lisinopril	Lisinopril	155	53
Tamsulosin Hcl	Tamsulosin Hcl	153	59
Gabapentin	Gabapentin	140	50
Metformin Hcl	Metformin Hcl	118	37
Allopurinol	Allopurinol	102	34
Trazodone Hcl	Trazodone Hcl	91	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	28
Hydrochlorothiazide	Hydrochlorothiazide	82	30
Potassium Chloride	Potassium Chloride	82	28
Pantoprazole Sodium	Pantoprazole Sodium	76	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	21
Zolpidem Tartrate	Zolpidem Tartrate	69	24
Escitalopram Oxalate	Escitalopram Oxalate	66	23
Metoprolol Succinate	Metoprolol Succinate	66	25
Bupropion Xl	Bupropion Hcl	62	19
Clonazepam	Clonazepam	57	13
Metformin Hcl Er	Metformin Hcl	56	20
Alendronate Sodium	Alendronate Sodium	55	16
Lorazepam	Lorazepam	54	14
Albuterol Sulfate Hfa	Albuterol Sulfate	53	22
Montelukast Sodium	Montelukast Sodium	51	12
Fluoxetine Hcl	Fluoxetine Hcl	49	18
Alprazolam	Alprazolam	48	17
Meloxicam	Meloxicam	43	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	15
Furosemide	Furosemide	41	20
Glimepiride	Glimepiride	40	14
Tramadol Hcl	Tramadol Hcl	40	15
Carvedilol	Carvedilol	38	13
Citalopram Hbr	Citalopram Hydrobromide	37	11
Atenolol	Atenolol	36	11
Famotidine	Famotidine	36	suppressed
Eliquis	Apixaban	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	12
Donepezil Hcl	Donepezil Hcl	32	11
Finasteride	Finasteride	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Xarelto	Rivaroxaban	28	suppressed
Glipizide Er	Glipizide	27	13
Spironolactone	Spironolactone	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Triamcinolone Acetonide	Triamcinolone Acetonide	21	18
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Prednisone	Prednisone	19	18
Warfarin Sodium	Warfarin Sodium	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Testosterone	Testosterone	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Baclofen	Baclofen	15	suppressed
Estradiol	Estradiol	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error